Table 3.
Comparison of DPT expression (based on DPT expression category) between different groups of patients (real-time PCR data)
| DPT expression change | ||||
|---|---|---|---|---|
| Under expression | No change | Overexpression | P-value | |
| Gender | ||||
| Male | 37.5% (9)* | 37.5% (9)* | 25.0% (6)* | 0.49 |
| Female | 35.7% (5)* | 21.4% (3)* | 42.9% (6)* | |
| Grade | ||||
| Well differentiated | 28.6% (4)* | 28.6% (4)* | 42.9 (6)* | 0.61 |
| Moderately differentiated | 40.9% (9)* | 31.8% (7)* | 27.3% (6)* | |
| Poorly differentiated | 0% (0)* | 100% (1)* | 0% (0)* | |
| Stage | ||||
| I & II | 38.5% (10)* | 34.6% (9)* | 26.9% (7)* | 0.66 |
| III & IV | 27.3% (3)* | 27.3% (3)* | 45.5% (5)* | |
| Lymph node involvement | ||||
| N0 | 36% (9)* | 36% (9)* | 28% (7)* | 0.75 |
| N>0 | 33.3% (4)* | 25% (3)* | 4.7% (5)* | |
| Tumor location | ||||
| Proximal | 50% (5)* | 30% (3)* | 20% (2)* | 0.59 |
| Distal | 32% (9)* | 32% (9)* | 36% (10)* | |
*Number of samples
DPT: Dermatopontin